SREBF2 and neoplasm: We observed that SREBF2 KD in the DAXX OE cells significantly attenuated the levels of lipogenic enzymes and tumor growth (Fig. 6g, h), implying that SREBP2 is a critical effector of DAXX’s oncogenic function.